Blair William & CO Ionis Pharmaceuticals Inc Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Blair William & CO holds 27,838 shares of IONS stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,838

Previous 16,628 67.42%

Holding current value

$1.28 Million

Previous $841,000 43.4%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$42.03 - $53.55 $471,156 - $600,295	11,210 Added 67.42%	27,838 $1.21 Million
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $12,322 - $14,662	284 Added 1.74%	16,628 $841,000
Q3 2023 Nov 09, 2023	SELL	$38.5 - $47.13 $1,540 - $1,885	-40 Reduced 0.24%	16,344 $741,000
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $60,430 - $75,394	1,740 Added 11.88%	16,384 $672,000
Q4 2022 Feb 10, 2023	SELL	$37.12 - $46.52 $7,423 - $9,304	-200 Reduced 1.35%	14,644 $553,000

Q3 2022 Nov 09, 2022	BUY	$36.54 - $48.66 $8,659 - $11,532	237 Added 1.62%	14,844 $657,000
Q2 2022 Aug 10, 2022	SELL	$31.71 - $43.0 $3,836 - $5,203	-121 Reduced 0.82%	14,607 $541,000
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $7,888 - $9,778	264 Added 1.83%	14,728 $546,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $1,280 - $1,755	-50 Reduced 0.34%	14,464 $440,000
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $141,740 - $171,364	4,226 Added 41.08%	14,514 $487,000
Q2 2021 Aug 12, 2021	SELL	$34.54 - $47.25 $30,257 - $41,391	-876 Reduced 7.85%	10,288 $410,000
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $170,040 - $255,120	-4,000 Reduced 26.38%	11,164 $502,000
Q4 2020 Feb 09, 2021	BUY	$45.3 - $60.27 $2,038 - $2,712	45 Added 0.3%	15,164 $857,000
Q3 2020 Nov 06, 2020	SELL	$47.45 - $62.95 $23,677 - $31,412	-499 Reduced 3.2%	15,119 $717,000
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $23,097 - $30,097	-493 Reduced 3.06%	15,618 $921,000
Q1 2020 May 11, 2020	SELL	$41.6 - $63.4 $8,694 - $13,250	-209 Reduced 1.28%	16,111 $762,000
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $93,806 - $113,700	1,742 Added 11.95%	16,320 $986,000
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $23,742 - $29,004	402 Added 2.84%	14,578 $873,000
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $30,610 - $42,467	-493 Reduced 3.36%	14,176 $911,000
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $9,472 - $14,529	179 Added 1.24%	14,669 $1.19 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $607 - $833	14 Added 0.1%	14,490 $783,000
Q2 2018 Aug 13, 2018	BUY	$40.53 - $50.7 $348,558 - $436,020	8,600 Added 146.36%	14,476 $603,000
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $21,070 - $26,313	-478 Reduced 7.52%	5,876 $259,000
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $45,270 - $57,951	900 Added 16.5%	6,354 $320,000
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $248,484 - $324,894	5,454	5,454 $277,000

Others Institutions Holding IONS

# of Institutions

398

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.54B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account